AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31

ASCENTAGE PHARMA GROUP INTERNATIONAL

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026

$15.36−0.01 (-0.07%)

Close on Oct 19, 2026

Dividends

No dividend per share appears in Ascentage Pharma Group International's annual filings since fiscal 2021.

Parsed from the XBRL in Ascentage Pharma Group International's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is AAPG.

Revenue growth-41.5% · median 54.9%

Gross margin91.5% · median 70.3%

Net margin-216.5% · median -64.3%

Advertisement
300 × 250